# Indacaterol in Heart Failure Patients: Any Role on Lung Fluid Regulation

> **NCT02598505** · PHASE3 · COMPLETED · sponsor: **Centro Cardiologico Monzino** · enrollment: 44 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Indacaterol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02598505
- **Lead sponsor:** Centro Cardiologico Monzino
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2016-11
- **Final completion:** 2016-11
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2020-01-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02598505

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02598505, "Indacaterol in Heart Failure Patients: Any Role on Lung Fluid Regulation". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT02598505. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*